RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ANTONUZZO L
Collezione AOU Novara

Items : 6

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours. in Journal of hepatology / J Hepatol. 2024 Mar;80(3):431-442. doi: 10.1016/j.jhep.2023.10.040. Epub 2023 Nov 15.

2024
AOU Novara

Celsa C; Cabibbo G; Fulgenzi CAM; Scheiner B; D'Alessio A; Manfredi GF; Nishida N; Ang C; Marron TU; Saeed A; Wietharn B; Pinter M; Cheon J; Huang YH; Lee PC; Phen S; Gampa A; Pillai A; Vivaldi C; Salani F; Masi G; Roehlen N; Thimme R; Vogel A; Schönlein M; von Felden J; Schulze K; Wege H; Galle PR; et alii...

Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25). in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Aug;22(4):102099. doi: 10.1016/j.clgc.2024.102099. Epub 2024 Apr 24.

2024
AOU Novara

Gambale E; Maruzzo M; Messina C; De Gennaro Aquino I; Vascotto IA; Rossi V; Bimbatti D; Cavasin N; Messina M; Mennitto A; Rebuzzi SE; Nasso C; Mercinelli C; Maiorano BA; Fanelli M; Sorarù M; Scolari F; Mela MM; Galli L; Salfi A; Rizzo M; Puglisi S; Orlando V; Fornarini G; Rametta A; Giannatempo P; Cerbone L; Doni L; Roviello G; et alii...

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer. in Nature medicine / Nat Med. 2023 Mar;29(3):605-614. doi: 10.1038/s41591-023-02240-8. Epub 2023 Mar 2.

2023
ASL Torino 4
AOU Novara

Tamburini E; Petrillo A; Gobba SM; Graham J; Longarini R; Garrone O; Zanaletti N; De Tursi M; Parisi A; Libertini M; Morelli C; Cergnul M; Depetris I; Ratti M; Fenocchio E; Zoratto F; Thomas A; Iveson T; Messina C; Pavarana M; Ross P; Rodriquenz MG; Stavraka C; Rosati G; Antonuzzo L; Mazzuca F; Merz V; Gelsomino F; Berardi R; et alii...

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry. in The Lancet. Oncology / Lancet Oncol. 2023 Apr;24(4):335-346. doi: 10.1016/S1470-2045(23)00056-6. Epub 2023 Mar 7.

2023
AOU Novara

Cortellini A; Tabernero J; Mukherjee U; Salazar R; Sureda A; Maluquer C; Ferrante D; Bower M; Sharkey R; Mirallas O; Plaja A; Cucurull M; Mesia R; Dalla Pria A; Newsom-Davis T; Van Hemelrijck M; Sita-Lumsden A; Apthorp E; Vincenzi B; Di Fazio GR; Tonini G; Pantano F; Bertuzzi A; Rossi S; Brunet J; Lambertini M; Pedrazzoli P; Biello F; D'Avanzo F; et alii...

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Porzio G; Tiseo M; Russano M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Metro G; Migliorino MR; Passiglia F; Ricciardi S; Zoratto F; Pecci F; Di Marino P; Mansueto G; De Tursi M; Tuzi A; Gori S; Della Gravara L; Macerelli M; Rastelli F; Chiari R; Gelibter A; Marchetti P; Antonuzzo L; Mazzoni F; et alii...

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Ficorella C; Addeo A; Friedlaender A; Banna GL; Di Maio M; Spinelli GP; Russo A; Adamo V; De Filippis M; Metro G; Simona C; Natalizio S; Migliorino MR; Landi L; Ricciardi S; Buti S; Minuti G; Nigro O; Cantini L; Bracarda S; Citarella F; Russano M; Filetti M; Zoratto F; Gori S; De Tursi M; Mansueto G; Rocco D; et alii...